Vaccination is one of the most cost-effective approaches in preventive medicine. Over the past 3 decades, new techniques in recombinant DNA and biotechnology have offered unprecedented opportunities for developing new vaccines. Many training opportunities exist to prepare individuals for research in immunology, molecular genetics, infectious diseases, and other specific aspects of vaccine development, but few training programs offer broad exposure to both laboratory and clinical trial aspects of vaccinology as a cohesive discipline. For the past 37 years, the Center for Vaccine Development of the University of Maryland School of Medicine has been involved in all aspects of vaccine development, from basic laboratory studies involving genetic construction of recombinant vaccines to Phase 1 through Phase 4 clinical trials. We propose to continue a formal training program in which individuals with M.D. or Ph.D. (or equivalent) degrees can be prepared specifically for careers in vaccinology, either to pursue basic vaccine development research or to conduct investigative clinical trials and translational research. Two new trainees will join the training program in each of the five years and training for each trainee will ensue fr 3 (sometimes 4) years. Support only for years 1 and 2 is requested in this proposal;support for the 3rd and possible 4th years will come from fellowships, research grants, or other sources. The Training Program in Vaccinology offers to all trainees a broad exposure to both the laboratory and clinical trial phases of vaccinology. Beyond this broad exposure, the program has two tracks to provide each trainee with intensive experience in either the laboratory aspects or the clinical phases of vaccinology, depending upon which track they choose. The Laboratory Track allows the training of basic scientists and physician-scientists in vaccine development laboratory research, particularly in the use of recombinant DNA technology to prepare new vaccine candidates and the use of modern immunological techniques to study the human humoral and cellular immune response to vaccines. The Clinical Track trains clinicians (internists or pediatricians) in trial design, protocol development, regulatory and ethical clearances, performance of clinical trials, data analysis and clinical translational research. The ultimate goal of this training program is to provide a well-trained cadre of individuals who can fully exploit the unprecedented opportunities now available in vaccine development.
Vaccines developed during the past few decades have been able to protect children and adults from infectious diseases that caused suffering and death in past generations. The tools of modern science allow new vaccines to be designed and tested and made available to protect the health of our population. We propose to continue our Training Program that trains scientists in how to develop new vaccines and doctors in how to test the candidate new vaccines in step-wise fashion to the point where we are sure of their safety and their ability to protect the public against infectious diseases that were not previously preventable.
|Coalson, Jenna E; Cohee, Lauren M; Buchwald, Andrea G et al. (2018) Simulation models predict that school-age children are responsible for most human-to-mosquito Plasmodium falciparum transmission in southern Malawi. Malar J 17:147|
|Durham, David P; Fitzpatrick, Meagan C; Ndeffo-Mbah, Martial L et al. (2018) Evaluating Vaccination Strategies for Zika Virus in the Americas. Ann Intern Med 168:621-630|
|Haidara, Fadima C; Tapia, Milagritos D; Sow, Samba O et al. (2018) Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Coadministered With Measles, Yellow Fever, and Meningitis A Vaccines in 9-Month-Old Malian Infants. J Infect Dis 218:606-613|
|Fitzpatrick, Meagan C; Gray, Glenda E; Galvani, Alison P (2018) The Challenge of Vanquishing HIV for the Next Generation-Facing the Future. JAMA Pediatr 172:609-610|
|Gopal, Radha; Rapaka, Rekha R; Kolls, Jay K (2017) Immune reconstitution inflammatory syndrome associated with pulmonary pathogens. Eur Respir Rev 26:|
|Fitzpatrick, Meagan C; Singer, Burton H; Hotez, Peter J et al. (2017) Saving lives efficiently across sectors: the need for a Congressional cost-effectiveness committee. Lancet 390:2410-2412|
|Buchwald, Andrea G; Coalson, Jenna E; Cohee, Lauren M et al. (2017) Insecticide-treated net effectiveness at preventing Plasmodium falciparum infection varies by age and season. Malar J 16:32|
|Salerno-Goncalves, Rosângela; Luo, David; Fresnay, Stephanie et al. (2017) Challenge of Humans with Wild-type Salmonella enterica Serovar Typhi Elicits Changes in the Activation and Homing Characteristics of Mucosal-Associated Invariant T Cells. Front Immunol 8:398|
|Galvani, Alison P; Durham, David P; Vermund, Sten H et al. (2017) California Universal Health Care Bill: an economic stimulus and life-saving proposal. Lancet 390:2012-2014|
|Galvani, Alison P; Fitzpatrick, Meagan C; Vermund, Sten H et al. (2017) Fund global health: Save lives and money. Science 356:1018-1019|
Showing the most recent 10 out of 42 publications